Microsoft has just rolled out the latest update version 1903 for its Windows operating system. The update brings several new features and along with that and includes a new ransomware protection feature to Windows Defender, which is a built-in virus protection software for Windows 10.
Those who are not aware of ransomware, these are a kind of virus that encrypts the data on the infected computer and then ask for ransom in the form of cryptocurrency to decrypt it.
So, if you are worried about your PC data protection and want to activate this feature, follow our step-by-step guide.
Pre-requisites:
- Windows 10 1903 update or newer
- Working internet connection
First things first:
- If you are not sure which Windows 10 version is installed on your PC, head to Windows Settings -> System-> About and scroll down to locate ‘Version’.
- Also, if you find that the 1903 version is not installed, head to Windows Update and check for the update.
Steps to follow:
1.Click on Start menu
2.Search for Windows Security and click on it or head to the Settings app and navigate to Update & Security
3.Under the Update & Security, head to Virus & Threat Protection option
4.Scroll down and locate Ransomware Protection and click on the option Manage ransomware protection
5.Enable Controlled Folder Access and login into Microsoft account to enable to protection
6.After this, click on configure Controlled Folder Access and select the folder you want to protect and monitor for the ransomware.
Also, do keep in mind, if you are using any third-party virus protection software like Norton, McAfee, etc then all these features will be managed by it and not the Windows Defender.
Nice you can also visit here
ReplyDeleteGood Post. I like your blog. Thanks for Sharing
ReplyDeleteInternet Speed Test
Great Article
ReplyDeleteVisit : https://thechineseinterpreter.com/09899312998-top-57-chinese-translator-surat/
Visit : https://thechineseinterpreter.com/chinese-russian-translator-ahmedabad/
Visit : https://thechineseinterpreter.com/top-53-chinese-translator-delhi-russian-translation-delhi-korean-interpreter-delhi/
Thanks. Also check Ghar Baithe Paise Kamane ke Asan Tarike Kya aap bhi online paise kamaana chahte hai. Humne is article me bataya hain ke kase aap legal aur tested methods ko use kar ke paise kama sakte hain.
ReplyDelete
ReplyDeleteNice Post Man, Keep it upTechnology and knowledge
A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample usabio inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for usabio HPV serum antibodies and HPV DNA. Serology for HPV 16 VLPs, E6, and E7 antibodies was performed on 49 of the 66 cases which were HPV-negative and a sample of 48 of the 866 cases which were HPV-positive in the original study. Moreover, 55 of the 66 formerly HPV-negative biopsies were also reanalyzed by a sandwich procedure in which the outer sections in a series of sections are used for histological review, while the inner sections are assayed by three different HPV PCR assays targeting different open reading frames (ORFs). No significant difference usabio was found in serology for HPV 16 proteins between the cases that were usabio originally HPV PCR-negative and -positive. Type-specific E7 PCR for 14 high-risk HPV types detected HPV DNA in 38 (69 per cent) of the 55 originally HPV-negative and amplifiable specimens. The HPV types detected were 16, 18, 31, 33, 39, 45, 52, and 58. Two (4 per cent) additional cases were only HPV DNA-positive by E1 and/or L1 consensus PCR. Histological analysis of the 55 specimens revealed that 21 were qualitatively inadequate. Only two of the 34 adequate samples were HPV-negative on all PCR tests, as against 13 of the 21 that usabio were usabio inadequate ( p< 0.001). Combining the data from this and the previous study and excluding inadequate specimens, the worldwide HPV prevalence in cervical carcinomas is 99.7 per cent. The presence of HPV in virtually all cervical usabio cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer. The extreme rarity of HPV-negative cancers reinforces the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
ReplyDelete